Clinicians can use new monoclonal antibody therapies to treat high-risk patients presenting with mild to moderate COVID-19 symptoms. However, despite the promise to depress viral loads, logistical and other challenges continue to stand in the way of larger-scale use. Still, some EDs are trying the therapeutics, with promising results.
The coronavirus vaccine rollout faces challenges from logistical supply issues and vaccine hesitancy among healthcare staff and the general public. From a reproductive health provider perspective, the big question is how to handle the rollout and overcome challenges on both the supply and demand sides.
Surgery center leaders should start educating staff about the vaccine candidates and create vaccine policies for employees and patients. Because vaccine demand is high, leaders also should prepare in case their facilities become designated vaccine administration sites.
The sudden and explosive growth of telehealth during COVID-19 demanded sorting out all kinds of logistics, reimbursement, and scheduling processes in short order. The frantic time frames to set it up did not exactly allow for careful ethical reflection.
Few patient access departments had successful remote work programs in place before COVID-19. Since the pandemic began, facilities have made some major adjustments. The following is a summary of how the field is faring with these unusual arrangements.